drugset / Trial / NCT00002817
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1/2
Unknown
30 enrolled
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill melanoma cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients with metastatic melanoma.
Timeline
- Start
- 1996-04
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sargramostim | Protein / enzyme biologic | — | — |
| Subject | vaccinia-GM-CSF vaccine | Vaccine | — | Other |